1. Home
  2. CPZ vs TARA Comparison

CPZ vs TARA Comparison

Compare CPZ & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Calamos Long/Short Equity & Dynamic Income Trust

CPZ

Calamos Long/Short Equity & Dynamic Income Trust

HOLD

Current Price

$13.06

Market Cap

255.4M

Sector

Finance

ML Signal

HOLD

Logo Protara Therapeutics Inc.

TARA

Protara Therapeutics Inc.

HOLD

Current Price

$4.09

Market Cap

236.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CPZ
TARA
Founded
N/A
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
255.4M
236.1M
IPO Year
2017
2014

Fundamental Metrics

Financial Performance
Metric
CPZ
TARA
Price
$13.06
$4.09
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$24.40
AVG Volume (30 Days)
82.2K
771.6K
Earning Date
01-01-0001
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
38.25
EPS
N/A
N/A
Revenue
N/A
$2,948,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.41
$2.97
52 Week High
$16.82
$7.82

Technical Indicators

Market Signals
Indicator
CPZ
TARA
Relative Strength Index (RSI) 58.68 46.96
Support Level $13.13 $3.69
Resistance Level $13.44 $4.23
Average True Range (ATR) 0.24 0.23
MACD 0.02 0.03
Stochastic Oscillator 68.14 44.83

Price Performance

Historical Comparison
CPZ
TARA

About CPZ Calamos Long/Short Equity & Dynamic Income Trust

Calamos L/S Equity & Dynamic Inc Trust is a trust company that seeks to provide current income and risk-managed capital appreciation, with an investment objective to deliver total return through a combination of capital appreciation and current income. The Fund invests in securities across sectors such as Industrials, Healthcare, Financials, Consumer Discretionary, and others, and holds securities with a broad range of maturities, with the average term to maturity typically ranging from two to ten years. Managed assets represent the Fund's total assets, including any assets attributable to leverage that may be outstanding, minus total liabilities other than debt representing financial leverage.

About TARA Protara Therapeutics Inc.

Protara Therapeutics Inc is a clinical-stage biopharmaceutical company focused on advancing its therapies for the treatment of cancer and rare diseases. Its drug development pipeline includes: TARA-002, an investigational cell therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs); and IV Choline Chloride, an investigational phospholipid substrate replacement therapy, for patients receiving parenteral support, or PS, which includes both nutrition and fluids.

Share on Social Networks: